Sectors

Legend Holdings and Kawin Technology-backed Sciwind topped up its coffers in a series C round to advance its metabolic disease drug pipeline.

UOB and the venture firm’s joint vehicle has reportedly reached a first close sized at more than half its ceiling and is on its way to a final close later this year.

The insurer has pledged $13.5m to startup accelerator and incubator Founders Factory through a partnership modelled after a similar five-year initiative in 2016.

Singtel Innov8 is set to exit cybersecurity technology developer Bitglass in an acquisition deal while Nio Capital contributed to marketing software developer Whale's $50m series B round.

WestCap and Caisse de dépôt et placement du Québec co-led a round valuing the Tether-backed crypto lending platform developer at over $3bn.

The reinsurance provider's corporate venturing arm is bolstering its portfolio development activities alongside the launch of its latest fund.

SoftBank helped the internet communication software developer secure $300m in a round which brought the company's overall funding to $697m.

The corporate-backed automotive e-commerce portal raised series E funding which will be used to accelerate its growth, increase brand awareness and expand into new markets.

SoftBank led a series D round which enabled the employee benefits software provider achieve unicorn status.

The Duchenne muscular dystrophy drug developer's initial public offering could prove an exit ramp for Roche and Merck & Co.

The Lundbeck, Chiesi Group and Li-Cor Biosciences-backed eye and bladder cancer therapeutics developer has filed to go public on Nasdaq in an offering with a $100m placeholder target.